{
  "entities": {
    "activities": {
      "8c811e49-8621-4327-8f7e-b3d9755dc6cb": "Alcohol History",
      "3767d91c-a0a8-49b8-b145-23cdae999708": "Antineoplastic therapies since discontinuation of study treatment",
      "55acc048-a432-4358-96ae-cff8e5915451": "Blood Draw",
      "3680c629-428f-465d-bb55-a0a49df14539": "Computed Tomography",
      "8b3eeea5-e596-4b6c-9149-5291abe4e2c8": "Demography",
      "3e1672cb-cdd4-4b72-aa9f-d6ab4d8c6715": "Diagnosis and extent of cancer",
      "9cca6d26-578c-405f-aad7-e38365a8d756": "Disposition Assessment (at the end of each study phase)",
      "826ce0d6-2f06-47a3-970c-83f7085a8bd7": "Drug Supply (IRT)",
      "51926bd8-3da3-4368-b65f-54955803f2b5": "EORTC QLQ-C30",
      "95261da0-25c9-4933-b98c-c067f9fcff0d": "EQ-5D-5L",
      "83023377-24f1-4c9b-b743-6391458d34a8": "Echocardiogram",
      "b6cc897e-dd65-4da0-b5f1-f1376c1c3498": "Electrocardiogram",
      "06c3e836-de8a-4ebf-808a-91f63b4647ac": "FACT-M subscale (16 questions)",
      "45384ea1-ae2e-4ee4-869b-64788d8162d8": "HIV History",
      "2b784ec2-96c6-4874-b456-8a151e76aab9": "IRT Registration- Enrollment",
      "33f6961d-89d9-4a79-880c-8a8be61240cf": "Inclusion/exclusion",
      "a31e24b0-e326-4355-8202-76b6ac591d60": "Intravenous Infusion",
      "6c172b90-4455-4f17-b4ba-49a9e8258f62": "Magnetic Resonance Imaging",
      "abf4234a-cf65-428c-b60b-fb34e39b91c7": "Newly acquired tumor tissue for central BRAF V600 mutation testing",
      "0c329e4a-82de-4a69-805e-fdb1459bde5a": "Ophthalmologic Examination",
      "10d729bd-97ea-4eb8-a9ab-a9aeb6cd5ebc": "Past and current medical conditions including cardiovascular medical history and risk factors",
      "b32f5160-c4b4-4f50-8918-db6dc8af3c6f": "Pharmacogenetic ICF",
      "9f3f009e-93ce-41c0-bbff-3abc8480c0b8": "Physical Examination",
      "d446dc74-dfd8-4264-9762-f75a88c9ced0": "Physical Examination (complete)",
      "984865c9-944a-45a8-9116-93274e080a98": "Prior antineoplastic therapies (meds, surgery, radiation)",
      "1446eb22-448e-4873-849a-f71d3b592732": "Smoking History",
      "0d6d578c-7d6b-484e-932b-5d00681defa4": "Study ICF",
      "fb83b287-6b46-4049-a7f9-e13e2e301d1b": "Treatment beyond progression ICF",
      "19626b14-df02-47aa-ab92-e32243081b72": "Tumor Biopsy",
      "2b68a32b-9d83-4ed4-9351-de296976d5e1": "Tumor tissue (archival or new) for central BRAF V600 mutation testing",
      "e1e3dd27-2f20-4640-b8ef-130ec0dd2c6a": "Urinalysis"
    },
    "plannedTimepoints": {},
    "encounters": {
      "fb70f690-a8ae-4d82-8c3e-751069fe761e": "Cycle 1 Day 1",
      "5dec46f0-3e03-4cdd-aec9-eab545ee5bae": "Cycle 2 Day 1",
      "3bfa929c-782f-49bd-9f60-79d0950621df": "Cycle 3 Day 1",
      "6c7a8e7c-b493-434f-8f14-e65f5001c231": "Subsequent Cycles Day 1",
      "257381e8-4c5a-4502-ae15-30a5f567b25e": "Cycle 1 Day 8",
      "d9032ff1-248a-429b-a7fb-a288126a40e4": "Cycle 2 Day 8",
      "768642d6-207b-4962-a898-22b4bd95aa78": "Cycle 1 Day 15",
      "23251eec-c01f-4d6f-bb5e-3b6b8f500a51": "Cycle 2 Day 15",
      "613c6091-8d92-4f7d-88c4-b5c274035ad2": "Cycle 3 Day 15",
      "8699676b-6d6f-4de0-af38-53640b7ce856": "120-Day Safety Follow Up",
      "39e5eab6-596e-486b-9d91-9e093b878252": "150-Day Safety Follow Up",
      "f377daac-b993-4d78-8dc5-8b2ede787d3f": "30-Day Safety Follow Up",
      "c671d405-da0d-4813-b8b9-63d06f6d04d1": "60-Day Safety Follow Up",
      "432841a2-05dd-4c21-b748-37eeb7c35583": "90-Day Safety Follow Up",
      "dc4ff0ed-83e5-445d-883e-2514fb782b5c": "End of Post Treatment Follow Up",
      "9942f465-e458-47b9-a3df-08412a87a2c2": "End of Study Treatment (EoT)",
      "a0541663-e73d-401a-ab15-23dbfea08ae1": "Screening (-28 to -1)",
      "6cee8695-25f2-4da6-84f3-344c1838aeef": "Survival Follow Up"
    },
    "epochs": {
      "d2ce3d97-97b2-4ed3-a125-3cbbe0a4125d": "Screening/Baseline",
      "efbc09c2-76cd-42a8-b04c-30b407372b2e": "Treatment (Cycle = 28 days)",
      "bb727805-e1de-4063-8f05-2422fed9bc37": "Follow-Up Period"
    },
    "activityGroups": {}
  },
  "cells": {
    "0d6d578c-7d6b-484e-932b-5d00681defa4|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "b32f5160-c4b4-4f50-8918-db6dc8af3c6f|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "2b784ec2-96c6-4874-b456-8a151e76aab9|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "fb83b287-6b46-4049-a7f9-e13e2e301d1b|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "8b3eeea5-e596-4b6c-9149-5291abe4e2c8|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "33f6961d-89d9-4a79-880c-8a8be61240cf|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "10d729bd-97ea-4eb8-a9ab-a9aeb6cd5ebc|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "3e1672cb-cdd4-4b72-aa9f-d6ab4d8c6715|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "8c811e49-8621-4327-8f7e-b3d9755dc6cb|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "1446eb22-448e-4873-849a-f71d3b592732|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "45384ea1-ae2e-4ee4-869b-64788d8162d8|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "984865c9-944a-45a8-9116-93274e080a98|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "3767d91c-a0a8-49b8-b145-23cdae999708|f377daac-b993-4d78-8dc5-8b2ede787d3f": "both",
    "3767d91c-a0a8-49b8-b145-23cdae999708|c671d405-da0d-4813-b8b9-63d06f6d04d1": "both",
    "3767d91c-a0a8-49b8-b145-23cdae999708|432841a2-05dd-4c21-b748-37eeb7c35583": "both",
    "3767d91c-a0a8-49b8-b145-23cdae999708|8699676b-6d6f-4de0-af38-53640b7ce856": "both",
    "3767d91c-a0a8-49b8-b145-23cdae999708|39e5eab6-596e-486b-9d91-9e093b878252": "both",
    "3767d91c-a0a8-49b8-b145-23cdae999708|dc4ff0ed-83e5-445d-883e-2514fb782b5c": "both",
    "3767d91c-a0a8-49b8-b145-23cdae999708|6cee8695-25f2-4da6-84f3-344c1838aeef": "both",
    "826ce0d6-2f06-47a3-970c-83f7085a8bd7|fb70f690-a8ae-4d82-8c3e-751069fe761e": "both",
    "9cca6d26-578c-405f-aad7-e38365a8d756|9942f465-e458-47b9-a3df-08412a87a2c2": "both",
    "9cca6d26-578c-405f-aad7-e38365a8d756|dc4ff0ed-83e5-445d-883e-2514fb782b5c": "both",
    "9cca6d26-578c-405f-aad7-e38365a8d756|6cee8695-25f2-4da6-84f3-344c1838aeef": "both",
    "d446dc74-dfd8-4264-9762-f75a88c9ced0|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "51926bd8-3da3-4368-b65f-54955803f2b5|fb70f690-a8ae-4d82-8c3e-751069fe761e": "both",
    "95261da0-25c9-4933-b98c-c067f9fcff0d|fb70f690-a8ae-4d82-8c3e-751069fe761e": "both",
    "06c3e836-de8a-4ebf-808a-91f63b4647ac|fb70f690-a8ae-4d82-8c3e-751069fe761e": "both",
    "abf4234a-cf65-428c-b60b-fb34e39b91c7|a0541663-e73d-401a-ab15-23dbfea08ae1": "both",
    "abf4234a-cf65-428c-b60b-fb34e39b91c7|fb70f690-a8ae-4d82-8c3e-751069fe761e": "both",
    "abf4234a-cf65-428c-b60b-fb34e39b91c7|3bfa929c-782f-49bd-9f60-79d0950621df": "both",
    "2b68a32b-9d83-4ed4-9351-de296976d5e1|a0541663-e73d-401a-ab15-23dbfea08ae1": "both"
  },
  "cellFootnotes": {},
  "metadata": {
    "model": "gemini-3-flash-preview",
    "extraction_type": "text"
  }
}